Challenger (ASX: CGF) reports strong H1 FY26 earnings, with a 369% rise in statutory NPAT to $339m and dividend up 7%. Read the key highlights here.
Challenger earnings: Statutory NPAT surges 369% in H1 FY26
Challenger (ASX: CGF) reports strong H1 FY26 earnings, with a 369% rise in statutory NPAT to $339m and dividend up 7%. Read the key highlights here.